References
- Aygen B, Doganay M, Sumerkan B, Yildiz O, Kayabas U. Clinical manifestations, complications, and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect 2002;32:485–93.
- Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91–9.
- Sofian M, Aghakhani A, Velayati AA, Banifazl M, Eslamifar A, Ramezani A. Risk factors for human brucellosis in Iran: a case–control study. Int J Infect Dis 2008;12: 157–61.
- Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352:2325–36.
- Joint WHO/FAO Expert Committee on Brucellosis, 6th report. WHO Tech Rep Ser 1986;740:1–132.
- Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007;4:1872–8.
- Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ 2008; 336:701–4.
- Acocella G, Bertrand A, Beytout J, Durrande JB, Garcia Rodriguez JA, Kosmidis J, et al. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrob Chemother 1989;23:433–9.
- Montejo JM, Alberola I, Gonzalez-Zarate P, Alvarez A, Alonso J, Canovas A, et al. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis 1993;16:671–6.
- Solera J, Espinosa A, Martínez-Alfaro E, Sánchez L, Geijo P, Navarro E, et al. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother 1997;41:80–4.
- Solera J, Geijo P, Largo J, Rodriguez-Zapata M, Gijón J, Martinez-Alfaro E, et al. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clin Infect Dis 2004;39:1776–82.
- Ranjbar M, Keramat F, Mamani M, Kia AR, Khalilian FO, Hashemi SH, et al. Comparison between doxycycline– rifampin–amikacin and doxycycline–rifampin regimens in the treatment of brucellosis. Int J Infect Dis 2007;11: 152–6.
- Hasanjani Roushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis 2006;42:1075–80.
- Pappas G, Christou L, Akritidis N, Tsianos EV. Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect 2006;12:823–5.
- Solís García del Pozo J, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One 2012;7:e32090.
- Lubani MM, Dubin KI, Sharda DC, Ndhar DS, Araj GF, Hafez HA, et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J 1989;8:75–8.
- Kosmidis J. Comparative therapeutic trials in human brucellosis. In: Daikos GK, Gramarellou G, editors. Proceedings of the IV Mediterranean Congress of Chemotherapy, Rhodes. Chemioterapia 1985;4(Suppl 2):669–70.
- Abramson O, Abu-Rashid M, Gorodischer R, Yagupsky P. Failure of short antimicrobial treatments for human brucellosis. Antimicrob Agents Chemother 1997;41:1621–2.
- Hashemi SH, Farshadi M. Comparison between doxycycline–streptomycin and doxycycline–rifampin drug regimens in treatment of brucellosis. Abstract 45. Program and Abstracts of the 5th Iranian Congress of Infectious Diseases and Tropical Medicine, Tehran, Iran, December 2–5, 1996.